Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MAP Pharma shares dive after FDA rejects migraine drug
MAP Pharma shares dive after FDA rejects migraine drug
MAP Pharma shares dive after FDA rejects migraine drug
Submitted by
admin
on March 27, 2012 - 9:15am
Source:
Reuters
News Tags:
FDA
migraines
MAP Pharmaceuticals
Headline:
MAP Pharma shares dive after FDA rejects migraine drug
Do Not Allow Advertisers to Use My Personal information
